“Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients”, Bangladesh J Pharmacol, vol. 10, no. 3, pp. 489–493, Jul. 2015, doi: 10.3329/bjp.v10i3.23079.